Longer-term cardiac safety and outcomes of dose dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with ...
Heart disease is the leading cause of adult death worldwide, making cardiovascular disease diagnosis and management a global ...
Whether revascularization by percutaneous coronary intervention (PCI) can improve event-free survival and left ventricular function in patients with severe ischemic left ventricular systolic ...
Heart disease is the leading cause of adult death worldwide, making cardiovascular disease diagnosis and management a global health priority. An echocardiogram, or cardiac ultrasound, is one of the ...
Left ventricular noncompaction is characterized by deep trabeculations in the LV endocardium in association with left ventricular hypertrophy, dilation or hypertrophy/dilation. Noncompaction of the ...
Heart disease is the leading cause of adult death worldwide, making cardiovascular disease diagnosis and management a global ...
Demographic, systemic sclerosis (SSc)-specific, and cardiac factors raised the risk for left ventricular systolic dysfunction (LVSD) in a study of patients with SSc. Researchers used the Johns Hopkins ...
Please provide your email address to receive an email when new articles are posted on . HF and LV dysfunction affect about 9% of adults aged 60 years and older, and there are effective treatments to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results